David C. Benedicto insider trades: Adamis Pharmaceuticals (ADMP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 18, 2022 | ADMP | ↓ Sell10b5-1 | 3,603 | $0.61 | $2K | Direct | Mar 22, 2022 (4d) |
| Dec 1, 2021 | ADMP | ↓ Sell | 13,554 | $0.79 | $11K | Direct | Dec 3, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David C. Benedicto's insider trades
David C. Benedicto is Chief Financial Officer at Adamis Pharmaceuticals (ADMP). Since Dec 1, 2021, David has reported no open-market purchases and 2 sales worth $13K on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (17% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADMP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.